Unique ID issued by UMIN | UMIN000004838 |
---|---|
Receipt number | R000005761 |
Scientific Title | Safety of stapler vs. non-stapler closure of the pancreatic remnant after distal pancreatectomy: a multicenter randomized controlled trial |
Date of disclosure of the study information | 2011/01/18 |
Last modified on | 2014/01/07 14:38:44 |
Safety of stapler vs. non-stapler closure of the pancreatic remnant after distal pancreatectomy: a multicenter randomized controlled trial
SNS-RCT
Safety of stapler vs. non-stapler closure of the pancreatic remnant after distal pancreatectomy: a multicenter randomized controlled trial
SNS-RCT
Japan |
Benign and malignant pancreatic neoplasms indicated for distal pancreatectomy
Hepato-biliary-pancreatic surgery |
Malignancy
NO
Tha aim of this study is to evaluate the effectiveness of the two most common surgical techniques for distal pancreatectomy: stapler versus non-stapler closure of the pancreatic remnant
Safety,Efficacy
Confirmatory
Phase III
Clinical pancreatic fistul rate
Operative time, bleeding, chemical pancreatic fistula rate, duration of drain placement, complications, duration of hospital stay, severe complication rate
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Active
YES
NO
Institution is considered as a block.
YES
Central registration
2
Treatment
Device,equipment | Maneuver |
Non-stapler closure: After mobilazation of the pancreatic body, the transection is performed with paen fracture method, surgical scalpel, or harmonic scalpel. After a ligation of the pancreatic duct, subsequent closure of the pancreatic remnant is achieved with a single stitched suture of the entire pancreatic remnant. No closure is available. The suture material of choice should be a slowly absorbable monofilament thread.
Stapler closure: Pancreatic resection and transection of the pancreatic body will be executed using a linear stapling device (Ethicon TLH60).
20 | years-old | <= |
90 | years-old | > |
Male and Female
1)Non-malignant or malignant pancreatic neoplasms indicated for distal pancreatectomy
2)Expected survival time more than 3 months
3)Open distal pancreatectomy is feasible
4)ECOG performance status <3
5)No functinal disturvance of each organ
6)Age >=20, <90
7)Confirmation ofinformed consent
1)Chemotherapy, immunotherapy, or radiotherapy before operation
2)Possibility of total pancreaterctomy, or combined celiac artery resection
3)Severe comorbid illness needing postoperative care under ICU
4)Severe psychiatric or neurologic diseases
5)Pregnancy
6)Lack fo compliance
140
1st name | |
Middle name | |
Last name | Kazuaki Shimada |
National Cancer Center Hospital
Hepatobiliary and pancreatic surgery division
5-1-1 Tsukiji; Chuo-ku, Tokyo Japan
03-3542-2511
kshimada@ncc.go.jp
1st name | |
Middle name | |
Last name | Kazuaki Shimada |
National Cancer Center Hospital
Hepatobiliary and pancreatic surgery division
5-1-1 Tsukiji; Chuo-ku, Tokyo Japan
03-3542-2511
kshimada@ncc.go.jp
National Cancer Center Hospital
National Cancer Center Hospital
Japan
A Grant-in-Aid for cancer research from the Ministry of Health, Welfare and Labor of Japan (21-7-5)
NO
国立がん研究センター中央病院
2011 | Year | 01 | Month | 18 | Day |
Unpublished
Completed
2010 | Year | 12 | Month | 21 | Day |
2011 | Year | 01 | Month | 15 | Day |
2013 | Year | 12 | Month | 01 | Day |
2013 | Year | 12 | Month | 31 | Day |
2014 | Year | 03 | Month | 01 | Day |
2014 | Year | 06 | Month | 01 | Day |
2011 | Year | 01 | Month | 07 | Day |
2014 | Year | 01 | Month | 07 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005761
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |